Alcoholic myopathy and acetaldehyde

Victor R. Preedy, David Crabb, Jaume Farrés, Peter W. Emery

Research output: Chapter in Book/Report/Conference proceedingConference contribution

15 Citations (Scopus)

Abstract

Alcoholic myopathy is characterized by biochemical and morphological lesions within muscle, ranging from impairment of muscle strength and loss of lean tissue to cellular disturbances and altered gene expression. The chronic form of the disease is five times more common than cirrhosis and is characterized by selective atrophy of type II (anaerobic) fibres: type I (aerobic) fibres are relatively protected. Although the causative agent is known (i.e. ethanol), the intervening steps between alcohol ingestion and the development of symptoms and lesions are poorly understood. However, acetaldehyde appears to have an important role in the aetiology of the disease. For example, alcohol is a potent perturbant of muscle protein synthesis in vivo, and this effect is exacerbated by cyanamide pre-dosage, which raises acetaldehyde concentrations. Acetaldehyde alone also reduces muscle protein synthesis in vivo and proteolytic activity in vitro. The formation of acetaldehyde protein adducts is another mechanism of putative importance in alcoholic myopathy. These adducts are formed within muscle in response to either acute or chronic alcohol exposure and the adducts are located preferentially within the sarcolemmal and sub-sarcolemmal regions. However, the significance of protein adduct formation is unclear since we do not currently know the identity of the adducted muscle proteins nor whether adduction alters the biochemical or functional properties of skeletal muscle proteins.

Original languageEnglish
Title of host publicationNovartis Foundation Symposium
Pages158-177
Number of pages20
Volume285
StatePublished - 2007

Publication series

NameNovartis Foundation Symposium
Volume285
ISSN (Print)15282511

Fingerprint

Acetaldehyde
Muscle Proteins
Muscular Diseases
Alcohols
Cyanamide
Muscles
Muscle Strength
Atrophy
Skeletal Muscle
Proteins
Fibrosis
Chronic Disease
Ethanol
Eating
Gene Expression

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Preedy, V. R., Crabb, D., Farrés, J., & Emery, P. W. (2007). Alcoholic myopathy and acetaldehyde. In Novartis Foundation Symposium (Vol. 285, pp. 158-177). (Novartis Foundation Symposium; Vol. 285).

Alcoholic myopathy and acetaldehyde. / Preedy, Victor R.; Crabb, David; Farrés, Jaume; Emery, Peter W.

Novartis Foundation Symposium. Vol. 285 2007. p. 158-177 (Novartis Foundation Symposium; Vol. 285).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Preedy, VR, Crabb, D, Farrés, J & Emery, PW 2007, Alcoholic myopathy and acetaldehyde. in Novartis Foundation Symposium. vol. 285, Novartis Foundation Symposium, vol. 285, pp. 158-177.
Preedy VR, Crabb D, Farrés J, Emery PW. Alcoholic myopathy and acetaldehyde. In Novartis Foundation Symposium. Vol. 285. 2007. p. 158-177. (Novartis Foundation Symposium).
Preedy, Victor R. ; Crabb, David ; Farrés, Jaume ; Emery, Peter W. / Alcoholic myopathy and acetaldehyde. Novartis Foundation Symposium. Vol. 285 2007. pp. 158-177 (Novartis Foundation Symposium).
@inproceedings{f83b073c4acd4fa0b7929c3597ba5aed,
title = "Alcoholic myopathy and acetaldehyde",
abstract = "Alcoholic myopathy is characterized by biochemical and morphological lesions within muscle, ranging from impairment of muscle strength and loss of lean tissue to cellular disturbances and altered gene expression. The chronic form of the disease is five times more common than cirrhosis and is characterized by selective atrophy of type II (anaerobic) fibres: type I (aerobic) fibres are relatively protected. Although the causative agent is known (i.e. ethanol), the intervening steps between alcohol ingestion and the development of symptoms and lesions are poorly understood. However, acetaldehyde appears to have an important role in the aetiology of the disease. For example, alcohol is a potent perturbant of muscle protein synthesis in vivo, and this effect is exacerbated by cyanamide pre-dosage, which raises acetaldehyde concentrations. Acetaldehyde alone also reduces muscle protein synthesis in vivo and proteolytic activity in vitro. The formation of acetaldehyde protein adducts is another mechanism of putative importance in alcoholic myopathy. These adducts are formed within muscle in response to either acute or chronic alcohol exposure and the adducts are located preferentially within the sarcolemmal and sub-sarcolemmal regions. However, the significance of protein adduct formation is unclear since we do not currently know the identity of the adducted muscle proteins nor whether adduction alters the biochemical or functional properties of skeletal muscle proteins.",
author = "Preedy, {Victor R.} and David Crabb and Jaume Farr{\'e}s and Emery, {Peter W.}",
year = "2007",
language = "English",
isbn = "9780470057667",
volume = "285",
series = "Novartis Foundation Symposium",
pages = "158--177",
booktitle = "Novartis Foundation Symposium",

}

TY - GEN

T1 - Alcoholic myopathy and acetaldehyde

AU - Preedy, Victor R.

AU - Crabb, David

AU - Farrés, Jaume

AU - Emery, Peter W.

PY - 2007

Y1 - 2007

N2 - Alcoholic myopathy is characterized by biochemical and morphological lesions within muscle, ranging from impairment of muscle strength and loss of lean tissue to cellular disturbances and altered gene expression. The chronic form of the disease is five times more common than cirrhosis and is characterized by selective atrophy of type II (anaerobic) fibres: type I (aerobic) fibres are relatively protected. Although the causative agent is known (i.e. ethanol), the intervening steps between alcohol ingestion and the development of symptoms and lesions are poorly understood. However, acetaldehyde appears to have an important role in the aetiology of the disease. For example, alcohol is a potent perturbant of muscle protein synthesis in vivo, and this effect is exacerbated by cyanamide pre-dosage, which raises acetaldehyde concentrations. Acetaldehyde alone also reduces muscle protein synthesis in vivo and proteolytic activity in vitro. The formation of acetaldehyde protein adducts is another mechanism of putative importance in alcoholic myopathy. These adducts are formed within muscle in response to either acute or chronic alcohol exposure and the adducts are located preferentially within the sarcolemmal and sub-sarcolemmal regions. However, the significance of protein adduct formation is unclear since we do not currently know the identity of the adducted muscle proteins nor whether adduction alters the biochemical or functional properties of skeletal muscle proteins.

AB - Alcoholic myopathy is characterized by biochemical and morphological lesions within muscle, ranging from impairment of muscle strength and loss of lean tissue to cellular disturbances and altered gene expression. The chronic form of the disease is five times more common than cirrhosis and is characterized by selective atrophy of type II (anaerobic) fibres: type I (aerobic) fibres are relatively protected. Although the causative agent is known (i.e. ethanol), the intervening steps between alcohol ingestion and the development of symptoms and lesions are poorly understood. However, acetaldehyde appears to have an important role in the aetiology of the disease. For example, alcohol is a potent perturbant of muscle protein synthesis in vivo, and this effect is exacerbated by cyanamide pre-dosage, which raises acetaldehyde concentrations. Acetaldehyde alone also reduces muscle protein synthesis in vivo and proteolytic activity in vitro. The formation of acetaldehyde protein adducts is another mechanism of putative importance in alcoholic myopathy. These adducts are formed within muscle in response to either acute or chronic alcohol exposure and the adducts are located preferentially within the sarcolemmal and sub-sarcolemmal regions. However, the significance of protein adduct formation is unclear since we do not currently know the identity of the adducted muscle proteins nor whether adduction alters the biochemical or functional properties of skeletal muscle proteins.

UR - http://www.scopus.com/inward/record.url?scp=38449102615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449102615&partnerID=8YFLogxK

M3 - Conference contribution

C2 - 17590994

AN - SCOPUS:38449102615

SN - 9780470057667

VL - 285

T3 - Novartis Foundation Symposium

SP - 158

EP - 177

BT - Novartis Foundation Symposium

ER -